$BRO

BROWN & BROWN, INC. (BRO): Results of Operations and Financial Condition

BROWN & BROWN, INC. (BRO) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 bro-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Brown & Brown, Inc. announces second quarter 2026 results, including total revenues of $1.7 billion, an increase of 30.4%; Organic Revenue decrease of 0.7%; growth of Organic Revenue with Contingents of 0.7%; diluted net incom

Original reporting
Published Jul 27, 2026, 9:03 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 27, 2026, 9:07 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$BRO
Bullish
high confidence
Mentioned
$BRO
Relevance
8/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$BROBullishMed
01

Why it matters

Investors can update near-term expectations for earnings power based on reported revenue growth, EPS, and adjusted margin trends, while monitoring organic revenue softness and margin direction.

02

Market read

This is a primary earnings datapoint with quantified revenue, EPS, and adjusted profitability measures that can drive same-day positioning and subsequent estimate revisions.

03

What to watch

Margin comparisons show EBITDAC-adjusted margin easing (35.7% vs 36.7%), which could matter if investors expect continued margin expansion.

Relevance 8/10Novelty 7/10Timing: after-hours SEC 8-K filing for Q2 2026 results

Background

The company filed an SEC Form 8-K with Exhibit 99.1 reporting unaudited second quarter 2026 financial results.

Company-level read

Ticker impact

$BROBullishHigh confidence
Context

Brown & Brown reported Q2 2026 results with total revenues of $1.7B (+30.4% YoY) and diluted EPS of $0.84.

Expected impact

Likely supportive for near-term sentiment, though organic revenue softness may temper upside versus pure headline growth.

Evidence & confidence

The filing provides multiple quantified earnings metrics (revenues, net income, EPS, margins) that directly inform valuation and near-term expectations.

Market effects

Reinsurance/insurance brokerage demand signals remain constructive, with growth driven by acquisitions/contingents rather than purely organic.

No specific regional breakdown provided; impact is company-specific rather than geographic.

No explicit international macro catalyst; results appear driven by company operations and deal-related revenue components.

Counterpoint

Organic revenue declined (down 0.7% YoY), so the headline growth may be more acquisition and contingents-driven than underlying organic momentum.

Key entities

  • Brown & Brown, Inc.

    Reported Q2 2026 financial results in an 8-K, including revenues, net income, EPS, and adjusted metrics.

  • J. Powell Brown

    CEO who commented on “great momentum” heading into the back half of the year.

Related articles

$BROMed

Why Are Brown & Brown (BRO) Shares Soaring Today

Brown & Brown (NYSE: BRO) shares rose about 5% after the company reported Q2 results. Revenue increased 30.4% year over year to $1.68B, slightly below analysts’ $1.72B estimate. Adjusted EPS was $1.07, in line with expectations, driving investor focus on strong growth despite the revenue miss.

$BROMed

Brown & Brown Q2 Earnings Call Highlights

Brown & Brown (NYSE:BRO) discussed Q2 results on its earnings call. CFO Andy Watts said Retail revenue rose 35.9% mainly from acquisitions, while Retail organic growth was pressured by a pharmacy consulting business and a litigation-related organic revenue adjustment. Specialty Distribution total revenue rose 28.1% on Accession, with EBITDAC margin down to 42.7%. BRO expects H2 Retail organic growth excluding contingents of 1.5% to 2.5% and Specialty 2% to 4%, and reaffirmed $30M-$40M integratio

$BROMedAI 8/10

Brown & Brown, Inc. announces second quarter 2026 results, including total revenues of $1.7 billion, an increase of 30.4%; Organic Revenue decrease of 0.7%; growth of Organic Revenue with Contingents

Brown & Brown, Inc. (NYSE:BRO) reported unaudited Q2 2026 results. Total revenues rose to $1.7 billion, up 30.4% year over year, while organic revenue fell 0.7%. Net income attributable to the company increased to $288 million, and diluted EPS was $0.84. For six months, revenues were $3.6 billion, up 33.0%.

$BROMedAI 8/10

Why Brown & Brown (BRO) Stock Is Down Today

Brown & Brown (NYSE: BRO) shares fell about 2.6% after Morgan Stanley downgraded the stock to Underweight from Equalweight and cut its price target, citing concerns over organic growth reset, a softer pricing cycle, Florida exposure, and tougher competition and hiring. Barclays raised its target to $76 from $72. Shares traded near $68.04.